JRF

M.Sc, M.Pharm, M.S, M.Tech in Pharmaceutical Chemistry, Medicinal Chemistry, Biotechnology or Equivalent with an exceptionally good academic record with a minimum CGPA of 6.0 on a 10.0 point scale.

First Class in M.Sc. Life sciences, Biotechnology, Biochemistry, Microbiology, Genetics, Zoology, Biomedical Sciences and other allied Sciences.

Doctoral Degree in Science, Engineering, Technology, Pharma, MD, MS from a recognized University or equivalent. CSIR-Centre for Cellular and Molecular Biology, Hyderabad is a premier Research Institute under the aegis of Council of Scientific & Industrial Research, an autonomous body under the Ministry of Science & Technology, Government of India.

M.Pharm or M.Sc Chemistry, Analytical Chemistry, Medicinal Plants, Phytochemistry from a recognized University, Institute. engagement of project staff in the programme Management Unit of Regional Raw Drug Repository of Trans Ganga Plain Region

First class M.Sc in Biological Sciences, Biotechnology, Pharmaceutical Sciences, Chemistry. Applicant must be qualified in any one of the following tests CSIR, UGC, ICMR including Lectureship Assistant Professorship OR GATE. National Level examination DST, DBT, MoE, ICMR, IIT etc.

First class M.Sc any field of Life Science Applicant must be qualified in any one of the following tests CSIR, UGC, ICMR including Lectureship Assistant Professorship OR GATE. National Level examination DST, DBT, MoE, ICMR, IIT etc

Graduation in Science B.Pharm, Life Sciences. Biotech, Zoology, and Botany with PG diploma in Clinical Research with interest in monitoring of interventional clinical trials.

Masters Degree in Life Sciences, MVSC, Engineering or Medicine from a recognised university or equivalent With at least 1 years of R&D experience in academic institution or relevant industry with NET & GATE Hands-on experience in cell culture

First class in M.Pharm with specialization in Pharmaceutics or equivalent from a recognized University Candidate with industrial experience in formulation development, drug delivery, medical devices will be given preference.